成人注意缺陷多动障碍治疗的长期心血管风险
该研究利用全国登记数据,纳入1998至2020年首次启动ADHD治疗的成年患者,按随访开始时每日限定日剂量(DDD)分为既往使用、<1 DDD/天和≥1 DDD/天三组。与既往使用者相比,≥1 DDD/天组卒中、心力衰竭及复合终点10年绝对风险升高,风险比分别为1.2、1.7和1.3,急性冠脉综合征无显著关联。
要点
- 高剂量ADHD治疗与卒中、心衰及复合终点长期风险升高相关。
- 急性冠脉综合征未见明显关联。
- 年轻患者长期高剂量治疗需关注心血管风险。
核心结论
- 长期较高剂量ADHD治疗可能与年轻成人卒中、心力衰竭及复合心血管终点风险升高相关,需进一步研究。
研究设计与样本
- 基于全国登记数据的队列研究,纳入1998至2020年首次启动ADHD治疗的成年患者。
- 随访开始时分为既往使用者、<1 DDD/天和≥1 DDD/天三组,并分析首次处方1年后的暴露。
主要发现
- ≥1 DDD/天组与既往使用者相比,卒中标准化10年绝对风险为2.1%(95%CI 1.8%-2.4%) vs 1.7%(95%CI 1.5%-1.9%),风险比1.2(95%CI 1.0-1.5)。
- 心力衰竭标准化10年绝对风险为1.2%(95%CI 0.9%-1.4%) vs 0.7%(95%CI 0.6%-0.8%),风险比1.7(95%CI 1.3-2.2)。
- 复合终点标准化10年绝对风险为3.9%(95%CI 3.4%-4.3%) vs 3.0%(95%CI 2.8%-3.2%),风险比1.3(95%CI 1.1-1.5)。
- 急性冠脉综合征未见明显关联,绝对风险1.0%(95%CI 0.8%-1.2%) vs 0.9%(95%CI 0.8%-1.0%)。
临床怎么用
- 对长期使用较高剂量ADHD治疗的年轻成人,应关注卒中与心力衰竭风险,个体化评估获益与风险。
局限性
- 研究为观察性设计,可能存在残余混杂,不能确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incrementing numbers of patients treated for attention-deficit/hyperactivity disorder (ADHD) call for scrutiny concerning long-term drug-safety. OBJECTIVES: This study aims to investigate associations between long-term use of ADHD treatment and cardiovascular outcomes. METHODS: Using nationwide registers, adult patients first-time initiated on ADHD treatment between 1998 and 2020 were identified. Exposure groups were prior users, <1 defined daily dose (DDD) per day, ≥1 DDD per day determined at start of follow-up, and 1 year after patients' first claimed prescription. Outcomes were acute coronary syndromes, stroke, heart failure, and a composite of the above. RESULTS: At start of follow-up, 26,357, 31,211, and 15,696 individuals were correspondingly categorized as prior users (42% female, median age: 30 years [Q1-Q3: 23-41 years]), <1 DDD per day (47% female, median age: 31 years [Q1-Q3: 24-41 years]), and ≥1 DDD per day (47% female, median age: 33 years [Q1-Q3: 25-41 years]), respectively. Comparing ≥1 DDD per day with prior users, elevated standardized 10-year absolute risk of stroke (2.1% [95% CI: 1.8%-2.4%] vs 1.7% [95% CI: 1.5%-1.9%]), heart failure (1.2% [95% CI: 0.9%-1.4%] vs 0.7% [95% CI: 0.6%-0.8%]), and the composite outcome (3.9% [95% CI: 3.4%-4.3%] vs 3.0% [95% CI: 2.8 %-3.2%]) was found-with corresponding risk ratios of 1.2 (95% CI: 1.0-1.5), 1.7 (95% CI: 1.3-2.2), and 1.3 (95% CI: 1.1-1.5). No apparent associations were found for acute coronary syndrome (1.0% [95% CI: 0.8%-1.2%] vs 0.9% [95% CI: 0.8%-1.0%]). CONCLUSIONS: Possible associations between elevated long-term cardiovascular risk and increasing dosage of ADHD treatment use in a young patient group should warrant further investigation.
引用
- Holt A, Strange JE, Rasmussen PV, et al. Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults. J Am Coll Cardiol. 2024. PMID: 38719367. doi:10.1016/j.jacc.2024.03.375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。